Marianne Grønlie Guren
机构: MD PhD, Oslo University Hospital
每年引用次数
引用次数
引用: 7,461
H-指数: 42
I10-指数 : 81
出版物: 182
Patient factors and quality of life outcomes differ among four subgroups of oncology patients based on symptom occurrence.
Guro Lindviksmoen Astrup , Kristin Hofsø , Kristin Bjordal , Marianne Grønlie Guren
Acta Oncologica 56 ( 3) 462 -470
23
2017
Health-related quality of life in patients with metastatic colorectal cancer, association with systemic inflammatory response and RAS and BRAF mutation status
Maria Thomsen , Marianne Grønlie Guren , Eva Skovlund , Bengt Glimelius
European Journal of Cancer 81 26 -35
7
2017
Anal cancer chemoradiotherapy outcome prediction using 18F-fluorodeoxyglucose positron emission tomography and clinicopathological factors
Espen Rusten , Bernt Louni Rekstad , Christine Undseth , Dagmar Klotz
British Journal of Radiology 92 ( 1097) 20181006
8
2019
High symptom burden is associated with impaired quality of life in colorectal cancer patients during chemotherapy:A prospective longitudinal study.
Kari Röhrl , Marianne Grønlie Guren , Guro Lindviksmoen Astrup , Milada Cvancarova Småstuen
European Journal of Oncology Nursing 44 101679 -101679
21
2020
Biochemical signs of impaired cobalamin status during and after radiotherapy for rectal cancer
Marianne Grønlie Guren , Jørn Schneede , Kjell Magne Tveit , Per Magne Ueland
International Journal of Radiation Oncology*Biology*Physics 60 ( 3) 807 -813
6
2004
Palliative pelvic radiotherapy for symptomatic incurable prostate cancer.
Marte Grønlie Cameron , Christian Kersten , Ingvild Vistad , Rene P van Helvoirt
Journal of Clinical Oncology 32
2014
Rising Incidence and Improved Survival of Anal Squamous Cell Carcinoma in Norway, 1987-2016.
Marianne Grønlie Guren , Bjarte Aagnes , Mari Nygård , Olav Dahl
Clinical Colorectal Cancer 18 ( 1)
12
2019
High Concordance and Negative Prognostic Impact of RAS/BRAF/PIK3CA Mutations in Multiple Resected Colorectal Liver Metastases
Tuva Høst Brunsell , Anita Sveen , Bjørn Atle Bjørnbeth , Bård I. Røsok
Clinical Colorectal Cancer 19 ( 1)
2
2020
Chemotherapy During Pregnancy for Advanced Colon Cancer: A Case Report.
Hanne Frydenberg , Nina Kittelsen Harsem , Åsa Ofigsbø , Hanne Skoglund
Clinical Colorectal Cancer 19 ( 2) 141 -144
2020
Palliative pelvic radiotherapy of symptomatic incurable prostate cancer - A systematic review
Marte Grønlie Cameron , Christian Kersten , Marianne Grønlie Guren , Sophie Dorothea Fosså
Radiotherapy and Oncology 110 ( 1) 55 -60
29
2014
Reirradiation of locally recurrent rectal cancer: a systematic review.
Marianne Grønlie Guren , Christine Undseth , Bernt Louni Rekstad , Morten Brændengen
Radiotherapy and Oncology 113 ( 2) 151 -157
53
2014
Palliative pelvic radiotherapy for symptomatic incurable prostate cancer – A prospective multicenter study
Marte Grønlie Cameron , Christian Kersten , Ingvild Vistad , Rene van Helvoirt
Radiotherapy and Oncology 115 ( 3) 314 -320
16
2015
Preoperative chemoradiotherapy for rectal cancer and impact on outcomes – A population-based study
Linn M. Åsli , Tom B. Johannesen , Tor Å. Myklebust , Bjørn Møller
Radiotherapy and Oncology 123 ( 3) 446 -453
14
2017
Age disparities in stage-specific colon cancer survival across seven countries: An International Cancer Benchmarking Partnership SURVMARK-2 population-based study.
Sophie Pilleron , Hadrien Charvat , Marzieh Araghi , Melina Arnold
International Journal of Cancer 148 ( 7) 1575 -1585
1
2021
Should calculation of chemotherapy dosage for bowel cancer be based on body composition
Ane Sørlie Kværner , Helene Harnæs , Dena Helene Alavi , Linnea Bärebring
Tidsskrift for Den Norske Laegeforening 140 ( 8)
2020
InterAACT: An international multicenter open label randomized phase II advanced anal cancer trial comparing cisplatin (CDDP) plus 5-fluorouracil (5-FU) versus carboplatin (CBDCA) plus weekly paclitaxel (PTX) in patients with inoperable locally recurrent (ILR) or metastatic disease.
Francesco Sclafani , Richard A. Adams , Cathy Eng , Al Bowen Benson
Journal of Clinical Oncology 33
9
2015
Is England closing the international gap in cancer survival
Sarah Walters , Sara Benitez-Majano , Patrick Muller , Michel P Coleman
British Journal of Cancer 113 ( 5) 848 -860
72
2015
No Differences in Symptom Burden Between Colorectal Cancer Patients Receiving Curative Versus Palliative Chemotherapy.
Kari Røhrl , Marianne Grønlie Guren , Christine Miaskowski , Bruce A. Cooper
Journal of Pain and Symptom Management 52 ( 4) 539 -547
10
2016
Patient-reported outcomes evaluating palliative radiotherapy and chemotherapy in patients with oesophageal cancer: a systematic review.
Cecilie Delphin Amdal , Anne-Birgitte Jacobsen , Marianne Grønlie Guren , Kristin Bjordal
Acta Oncologica 52 ( 4) 679 -690
19
2013
Impaired health-related quality of life after chemoradiotherapy for anal cancer: late effects in a national cohort of 128 survivors.
Anne Gry Bentzen , Lise Balteskard , Eva Hoff Wanderås , Gunilla Frykholm
Acta Oncologica 52 ( 4) 736 -744
69
2013